Walgreens Boots Alliance, Inc. - Common Stock (WBA)
10.69
-0.09 (-0.83%)
NASDAQ · Last Trade: Apr 11th, 3:09 AM EDT
The rollout follows a pilot program with Wolt, DoorDash’s international arm, in Helsinki, Finland, where Coco robots have been making deliveries since early this year.
Via Stocktwits · April 10, 2025
Everybody loves dividends as they provide a passive income stream and more than one way to reap a return from an investment. Dividend-paying stocks are generally less volatile by nature, another positive benefit in the current landscape.
Via Talk Markets · April 10, 2025
U.S. stock futures were volatile on Wednesday after the equities reversed gains on Tuesday following Donald Trump's 104% tariff on China.
Via Benzinga · April 9, 2025
Apple, Tesla, Amazon, and Nvidia shares dropped. Walgreens reported good earnings. All sectors of S&P 500 closed in the red.
Via Benzinga · April 9, 2025
Walgreens reports Q2 revenue beat with strong pharmacy growth, but earnings fall amid weaker retail sales and U.S. Healthcare shifts.
Via Benzinga · April 8, 2025
Pharmacy chain Walgreens Boots Alliance (NASDAQ:WBA) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 4.1% year on year to $38.59 billion. Its non-GAAP profit of $0.63 per share was 21% above analysts’ consensus estimates.
Via StockStory · April 8, 2025
U.S. stock futures rose on Tuesday following a volatile day of trading on Monday that led the indices to close on a mixed note.
Via Benzinga · April 8, 2025
Via Benzinga · April 8, 2025
Via Benzinga · April 8, 2025
Via Benzinga · April 8, 2025
Pharmacy chain Walgreens Boots Alliance (NASDAQ:WBA) will be reporting results tomorrow before market open. Here’s what to look for.
Via StockStory · April 7, 2025
Via Benzinga · April 7, 2025
Via The Motley Fool · April 3, 2025
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the consumer retail industry, including Walgreens (NASDAQ:WBA) and its peers.
Via StockStory · April 3, 2025
Via Benzinga · April 2, 2025
Realty Income, Main Street Capital, and the JPMorgan Equity Premium Income ETF deliver reliable monthly dividends for conservative income investors.
Via The Motley Fool · April 2, 2025
According to Bloomberg, a monthly prescription of Zepbound via Hims' platform would cost $1,899 — $800 more than Lilly's list price for the drug.
Via Stocktwits · April 1, 2025
High dividend yields can signal either financial strength or serious trouble. Here's what you need to know about today's top S&P 500 dividend payers.
Via The Motley Fool · March 28, 2025
Via The Motley Fool · March 27, 2025
Walgreens has had an impressive run over the past six months. While the S&P 500 has been flat, the stock has returned 22.7% and now trades at $11.12. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
Via StockStory · March 27, 2025